BiotechTube

Nivolumab 100 MG in 10 ML Injection

Phase 2UNKNOWN
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Upper Urinary Tract Urothelial Carcinoma

Conditions

Upper Urinary Tract Urothelial Carcinoma

Trial Timeline

Dec 25, 2020 → Dec 30, 2024

NCT ID
NCT05160285

About Nivolumab 100 MG in 10 ML Injection

Nivolumab 100 MG in 10 ML Injection is a phase 2 stage product being developed by Ono Pharmaceutical for Upper Urinary Tract Urothelial Carcinoma. The current trial status is unknown. This product is registered under clinical trial identifier NCT05160285. Target conditions include Upper Urinary Tract Urothelial Carcinoma.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT05160285Phase 2UNKNOWN

Competing Products

20 competing products in Upper Urinary Tract Urothelial Carcinoma

See all competitors
ProductCompanyStageHype Score
Remimazolam TosilateJiangsu Hengrui MedicineApproved
85
ABBV-950 + BOTOX + Placebo for ABBV-950AbbViePhase 1
33
BOTOX + Placebo for BOTOXAbbViePhase 2
52
BOTOXAbbVieApproved
85
MK-3475 and BCGMerckPhase 2
52
Montelukast + PlaceboMerckApproved
85
Muntelukast + PlaceboMerckPhase 3
77
IFF flavor 316 282, Paracetamol, PseudoephedrineNovartisPhase 3
77
Paracetamol (500 mg)/dimethindene maleate (1 mg)/ phenylephrine hydrochloride (10 mg) tablets + Paracetamol (500 mg) tabletsNovartisPhase 3
77
diclofenac potassium + nimesulideNovartisApproved
85
Diclofenac gelNovartisApproved
85
IFF flavor 316 282, Paracetamol , Phenylephrine, GuaifenesinNovartisPhase 3
77
Domvanalimab + Zimberelimab + Capecitabine + Fluorouracil + Leucovorin + Oxaliplatin + NivolumabGilead SciencesPhase 3
76
Azithromycin SRPfizerPhase 3
76
NivolumabBristol Myers SquibbPre-clinical
22
NivolumabBristol Myers SquibbPre-clinical
22
REGN475/SAR164877 + Placebo (for REGN475/SAR164877)Regeneron PharmaceuticalsPhase 2
51
IPN10200 + IPN10200 Placebo + DysportIpsenPhase 1/2
38
AboBoNT-A + OnaBoNT-AIpsenApproved
82
Botulinum toxin type AIpsenPhase 3
74

Other Products from Ono Pharmaceutical

Sivelestat sodium hydrate + Sivelestat sodium hydrateApproved
85
Abatacept + Placebo matching with Abatacept + MethotrexateApproved
85
Rivastigmine transdermal patchApproved
85
Sitagliptin phosphatePhase 3
77
ONO-4538 + Carboplatin + Paclitaxel + Bevacizumab + PlaceboPhase 3
77